DTwP-HepB-Hib-IPV (SHAN6) vaccine

Diphtheria-Tetanus-whole-cell Pertussis-Hepatitis B-Haemophilus influenzae type B-Inactivated poliovirus vaccine (SHAN6) · Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DTwP-HepB-Hib-IPV (SHAN6) vaccine, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand [Phase 3]

See pricing